NCT Number: NCT02388100
The GRADE Capillary Blood Collection Pilot Study
This pilot study is planned to validate the comparability of HbA1c results obtained from whole blood collection via venous phlebotomy versus a capillary collection of whole blood. The participant will self-collect capillary blood into HbA1c prep vials containing a buffer; these prep vials will be sent to the CBL at ambient temperature via US Postal System (USPS) mail. The feasibility of self-collection of these capillary samples by GRADE participants will also be evaluated.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Southwestern American Indian Center, Phoenix, Arizona, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Current GRADE participant with a scheduled follow-up visit
Exclusion criteria
- GRADE participants attending first quarterly (Month 3) visit or an annual visit
Treatment and study plan
Primary outcomes
-
HbA1c obtained from venous versus capillary measurements at one point in time for each participant.
Time frame: Cross sectional
Sponsors and collaborators
Lead sponsor
GRADE Study Group
Other
Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry information
Official study title
The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study) Capillary Blood Collection: A Pilot Study
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Mar 13, 2015
- Registry last updated
- Nov 15, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
NCT05872620
Body Weight, Diabetes Mellitus
Pelham, Alabama, United States
View Trial DetailsA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06221969
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsA Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
NCT05971940
Diabetes Mellitus, Diabetes Mellitus, Type 2
Sheffield, Alabama, United States
View Trial DetailsMontbretin Clinical Trial in Healthy Volunteers and Type 2 Diabetics
NCT05826054
Diabetes Mellitus, Diabetes Mellitus, Type 2
Vancouver, British Columbia, Canada
View Trial Details